Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes

Diabetes Care

Volumn 37, Issue 12, 2014, Pages 3317-3324

  O'Connor, Patrick J ^a   Schmittdiel, Julie A ^b   Pathak, Ram D ^c   Harris, Ronald I ^d   Newton, Katherine M ^e   Ohnsorg, Kris A ^a   Heisler, Michele ^f   Sterrett, Andrew T ^g   Xu, Stanley ^g   Dyer, Wendy T ^b   Raebel, Marsha A ^g   Thomas, Abraham ^h   Schroeder, Emily B ^g   Desai, Jay R ^a   Steiner, John F ^g  

^a HEALTHPARTNERS INSTITUTE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c MARSHFIELD CLINIC   (United States)

^d GEISINGER MEDICAL CENTER   (United States)

^e GROUP HEALTH RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g KAISER PERMANENTE   (United States)

^h HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIABETES EDUCATOR; DIABETES MELLITUS; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; METABOLIC REGULATION; OUTCOME ASSESSMENT; PHARMACIST; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; TELEPHONE INTERVIEW; ADOLESCENT; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATIENT EDUCATION; PHYSIOLOGIC MONITORING; PROCEDURES; TELEPHONE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD PRESSURE; CHOLESTEROL, LDL; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PATIENT EDUCATION AS TOPIC; PHARMACISTS; TELEPHONE; YOUNG ADULT;

EID: 84911862469     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0596     Document Type: Article

References (29)

1. O'Connor PJ. Improving medication adherence: challenges for physicians, payers, and policy makers. Arch Intern Med 2006;166:1802-1804
2. Karter AJ, Parker MM, Moffet HH, Ahmed AT, Schmittdiel JA, Selby JV. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res 2009;44:1640-1661
3. Raebel MA, Ellis JL, Carroll NM, et al. Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders. J Gen Intern Med 2012;27:57-64
4. Steiner JF. Rethinking adherence. Ann Intern Med 2012;157:580-585
5. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-497
6. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med 2007;167:540-550
7. McDonald KM, Chang C, Schultz E. Through the Quality Kaleidoscope: Re flections on the Science and Practice of Improving Health Care Quality. Closing the Quality Gap: Revisiting the State of the Science. Rockville, MD, Agency for Healthcare Research and Quality, 2013
8. Aubert RE, Herman WH, Waters J, et al. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trial. Ann Intern Med 1998;129:605-612
9. Tricco AC, Ivers NM, Grimshaw JM, et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet 2012;379:2252-2261
10. Derose SF, Green K, Marrett E, et al. Automated outreach to increase primary adherence to cholesterol-lowering medications. JAMA Intern Med 2013;173:38-43
11. Vollmer WM, Feldstein A, Smith DH, et al. Use of health information technology to improve medication adherence. Am J Manag Care 2011;17:SP79-SP87
12. Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med 2012;157:785-795
13. Desai JR, Wu P, Nichols GA, Lieu TA, O'Connor PJ. Diabetes and asthma case identification, validation, and representativeness when using electronic health data to construct registries for comparative effectiveness and epidemiologic research. Med Care 2012;50(Suppl.):S30-S35
14. Nichols GA, Desai J, Elston Lafata J, et al.; SUPREME-DM Study Group. Construction of a multisite DataLink using electronic health records for the identi fi cation, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project. Prev Chronic Dis 2012;9:E110
15. Heisler M, Hofer TP, Schmittdiel JA, et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensi fication of medications cluster randomized, controlled pragmatic trial. Circulation 2012;125:2863-2872
16. Heisler M, Hofer TP, Klamerus ML, et al. Study protocol: the Adherence and Intensification of Medications (AIM) study - a cluster randomized controlled effectiveness study. Trials 2010;11:95
17. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665
18. Baigent C, Blackwell L, Emberson J, et al.; Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376:1670-1681
19. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-1589
20. Fischer MA. Chipping away: improving primary medication adherence. JAMA Intern Med 2013;173:44-45
21. Schmittdiel JA, Uratsu CS, Karter AJ, et al. Why don ' t diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensifi cation. J Gen Intern Med 2008;23:588-594
22. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006;12:239-245
23. O'Connor PJ, Sperl-Hillen JM, Rush WA, et al. Impact of electronic health record clinical decision support on diabetes care: a randomized trial. Ann Fam Med 2011;9:12-21
24. Colhoun HM, Betteridge DJ, Durrington PN, et al.; CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004;364:685-696
25. Stuart BC, Simoni-Wastila L, Zhao L, Lloyd JT, Doshi JA. Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diabetes Care 2009;32:647-649
26. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007;297:177-186
27. Aubert RE, Yao J, Xia F, Garavaglia SB. Is there a relationship between early statin compliance and a reduction in healthcare utilization? Am J Manag Care 2010;16:459-466
28. Franklin JM, Shrank WH, Pakes J, et al. Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence. Med Care 2013;51:789-796
29. Bryson CL, Au DH, Young B, McDonell MB, Fihn SD. A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp). Med Care 2007;45:497-504